UK biotech Engitix has raised a $25 million series A extension from existing investor Netherton Investments, investing on behalf of BlueCrest Capital Management co-founder Mike Platt. The funding will ...
Age-related intervertebral disc (IVD) pathologies are a major driver of chronic low back pain and disability. Long framed as “wear and tear,” disc ...
Extracellular vesicles (EVs), including exosomes, microvesicles, apoptotic bodies, and many other EV subtypes, have emerged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback